Search Browse Earnings

PRECIGEN, INC.

Nasdaq:PGEN

Pharmaceutical Preparations·GERMANTOWN, MD

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

PRECIGEN, INC. — SlamSEC

Precigen, Inc. is an American biotechnology company.

CFO

Thomasian Harry Jr.

Revenue

$32.0M

-64.7% YoY

FY 2022

Adj. EBITDA

-$31.1M

-97.2% margin

FY 2020

Net Income

$28.3M

88.5% margin

FY 2024

EPS (Diluted)

$0.14

FY 2024

Stock Price

$3.51

+0.0%

2026-03-10

52W Range

$1.11 – $5.46

P/E Ratio

25.1x

Market Cap

$1.2B

Cash

$7.6M

FY 2024

Total Debt

$223.1M

FY 2022

Net Debt

$215.5M

FY 2022

Enterprise Value

$1.5B

Debt / EBITDA

-6.9x

FY 2022

EV / EBITDA

-46.9x

Employees

—